Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GF Stock Summary
Top 10 Correlated ETFs
GF
In the News
GF Financial details
Company Rating
Sell
Market Cap
144M
Income
19.43M
Revenue
-8.23M
Book val./share
-
Cash/share
-
Dividend
0.07
Dividend %
0.83%
Employees
-
Optionable
No
Shortable
Yes
Earnings
07 Mar 2024
P/E
-1.32
Forward P/E
-
PEG
0.11
P/S
-1.38
P/B
0.87
P/C
-
P/FCF
-
Quick Ratio
0.03
Current Ratio
0.01
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.14
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-20.64%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-11.11%
SMA50
-
SMA100
-
Inst Own
32.1%
Inst Trans
0.57%
ROA
-65%
ROE
-51%
ROC
-0.66%
Gross Margin
100%
Oper. Margin
101%
Profit Margin
101%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.38-9.41
52W High
-7.89%
52W Low
+18.43%
RSI
34
Rel Volume
1.47
Avg Volume
29.64K
Volume
43.45K
Perf Week
-3.49%
Perf Month
-2.7%
Perf Quarter
11.57%
Perf Half Y
5.47%
-
-
-
-
Beta
1.128
-
-
Volatility
0.04%, 0.15%
Prev Close
0.18%
Price
8.29
Change
0.24%
GF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.07 | 6.37 | 0.7 | -6.32 | 0 | |
Net income per share | 4.99 | 6.28 | 0.59 | -6.4 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.76 | 1.23 | 0.25 | 0 | 0 | |
Book value per share | 18.03 | 21.75 | 16.58 | 9.71 | 0 | |
Tangible book value per share | 18.67 | 22.72 | 16.84 | 9.71 | 0 | |
Share holders equity per share | 18.03 | 21.75 | 16.58 | 9.71 | 0 | |
Interest debt per share | 0 | 0.01 | 0 | 0 | 0 | |
Market cap | 248.06M | 295.43M | 230.01M | 131.13M | 0 | |
Enterprise value | 246M | 291M | 229.74M | 131.11M | -92.35K | |
P/E ratio | 3.14 | 3.03 | 25.03 | -1.23 | 0 | |
Price to sales ratio | 3.09 | 2.99 | 21.23 | -1.25 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.87 | 0.88 | 0.89 | 0.81 | 0 | |
PTB ratio | 0.87 | 0.88 | 0.89 | 0.81 | 0 | |
EV to sales | 3.07 | 2.94 | 21.2 | -1.25 | 0 | |
Enterprise value over EBITDA | 3.12 | 2.98 | 25 | -1.23 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.32 | 0.33 | 0.04 | -0.81 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.03 | -0.05 | -0.03 | 0 | 0 | |
Current ratio | 0.01 | 0.01 | 0 | 0.01 | 0.1 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.15 | -0.01 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 44.99 | 55.43 | 14.86 | 37.39 | 0 | |
ROIC | 0.27 | 0.29 | 0.04 | -0.66 | 0.13 | |
Return on tangible assets | 0.26 | 0.25 | 0.03 | -0.65 | 0.13 | |
Graham Net | 0.87 | -0.85 | -4.25 | 0.01 | 0 | |
Working capital | -3.21M | -32.35M | -76.37M | -739.94K | -859.25K | |
Tangible asset value | 295.34M | 352.74M | 261.56M | 161.36M | 184.42M | |
Net current asset value | -3.21M | -32.35M | -76.37M | -1.12M | -859.25K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 43.95K | 199.13K | 198.84K | 14.6K | 8.2K | |
Average payables | 24.49M | 17.98M | 54.56M | 38.57M | 853.97K | |
Average inventory | 4.99M | 5.19M | 6.62M | 7.67M | 1.25M | |
Days sales outstanding | 0.09 | 1.4 | 0.65 | -0.03 | 0.09 | |
Days payables outstanding | 484.76 | 4.54K | 8.71K | 147.46 | 0 | |
Days of inventory on hand | 1.5K | 54.49 | 1.46K | 490.03 | 0 | |
Receivables turnover | 4.03K | 261.2 | 561.13 | -10.63K | 3.87K | |
Payables turnover | 0.75 | 0.08 | 0.04 | 2.48 | 0 | |
Inventory turnover | 0.24 | 6.7 | 0.25 | 0.74 | 0 | |
ROE | 0.28 | 0.29 | 0.04 | -0.66 | 0.13 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | -0.68 | 0.1 | 0.1 | 0 | |
Net income per share | -0.05 | -0.11 | 0.65 | 0.65 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0.01 | 0.01 | 0 | |
Book value per share | 9.28 | 9.28 | 10.57 | 10.57 | 0 | |
Tangible book value per share | 9.28 | 9.28 | 10.57 | 10.57 | 0 | |
Share holders equity per share | 9.28 | 9.28 | 10.57 | 10.57 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 121.05M | 137.22M | 155.48M | 153.6M | 0 | |
Enterprise value | 121.03M | 137.2M | 155.33M | 153.45M | -92.35K | |
P/E ratio | -32.22 | -18.26 | 3.49 | 3.45 | 0 | |
Price to sales ratio | 705.51 | -11.59 | 90.47 | 89.38 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.75 | 0.85 | 0.86 | 0.85 | 0 | |
PTB ratio | 0.75 | 0.85 | 0.86 | 0.85 | 0 | |
EV to sales | 705.42 | -11.59 | 90.39 | 89.29 | 0 | |
Enterprise value over EBITDA | -241.44 | -71.54 | 15.49 | 15.3 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.01 | -0.01 | 0.07 | 0.07 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.03 | 0.01 | -0.01 | -0.01 | 0 | |
Current ratio | 0.28 | 0.01 | 1.02 | 0.05 | 0.1 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 3.49 | -0.05 | 0.36 | 0.36 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.36 | 4.75 | 12.44 | 12.44 | 0 | |
ROIC | 0 | -0.01 | 0 | 0 | 0 | |
Return on tangible assets | -0.01 | -0.01 | 0.06 | 0.06 | 0 | |
Graham Net | -0.06 | 0.01 | -0.29 | -0.44 | 0 | |
Working capital | -787.34K | -739.94K | 120.98K | -4.96M | -859.25K | |
Tangible asset value | 161.4M | 161.36M | 180.78M | 180.78M | 184.42M | |
Net current asset value | -787.34K | -1.12M | 120.98K | -4.96M | -859.25K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 121.2K | 9.88K | 50.71K | 91.54K | 0 | |
Average payables | 0 | 374.91K | 374.91K | 0 | 0 | |
Average inventory | 250.28K | 1.25M | 1.25M | -2.54M | 0 | |
Days sales outstanding | 5.18 | -0.08 | 4.79 | 4.79 | 0 | |
Days payables outstanding | 0 | 82.95 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 275.66 | 0 | 0 | 0 | |
Receivables turnover | 17.37 | -1.2K | 18.77 | 18.77 | 0 | |
Payables turnover | 0 | 1.08 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0.33 | 0 | 0 | 0 | |
ROE | -0.01 | -0.01 | 0.06 | 0.06 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
GF Frequently Asked Questions
What is The New Germany Fund, Inc. stock symbol ?
The New Germany Fund, Inc. is a DE stock and trading under the symbol GF
What is The New Germany Fund, Inc. stock quote today ?
The New Germany Fund, Inc. stock price is $8.29 today.
Is The New Germany Fund, Inc. stock public?
Yes, The New Germany Fund, Inc. is a publicly traded company.